
Charanjit Aulakh
Examiner (ID: 11601)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1612, 1203, 1621 |
| Total Applications | 3765 |
| Issued Applications | 2855 |
| Pending Applications | 383 |
| Abandoned Applications | 582 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 185179
[patent_doc_number] => 07648995
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-19
[patent_title] => 'R(—)-11-hydroxyaporphine derivatives and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/105024
[patent_app_country] => US
[patent_app_date] => 2005-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12639
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/648/07648995.pdf
[firstpage_image] =>[orig_patent_app_number] => 11105024
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/105024 | R(—)-11-hydroxyaporphine derivatives and uses thereof | Apr 12, 2005 | Issued |
Array
(
[id] => 341675
[patent_doc_number] => 07501433
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-10
[patent_title] => 'Opioid and opioid-like compounds and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/104281
[patent_app_country] => US
[patent_app_date] => 2005-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12762
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/501/07501433.pdf
[firstpage_image] =>[orig_patent_app_number] => 11104281
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/104281 | Opioid and opioid-like compounds and uses thereof | Apr 11, 2005 | Issued |
Array
(
[id] => 5700870
[patent_doc_number] => 20060217555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'PREPARATION OF CABERGOLINE'
[patent_app_type] => utility
[patent_app_number] => 11/100934
[patent_app_country] => US
[patent_app_date] => 2005-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2302
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20060217555.pdf
[firstpage_image] =>[orig_patent_app_number] => 11100934
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/100934 | Preparation of cabergoline | Apr 6, 2005 | Issued |
Array
(
[id] => 7691397
[patent_doc_number] => 20070232636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Substituted Diaza-Spiro-[5.5]-Undecane Derivaties and Their Use as Neurokinin Antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/547889
[patent_app_country] => US
[patent_app_date] => 2005-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20797
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20070232636.pdf
[firstpage_image] =>[orig_patent_app_number] => 11547889
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/547889 | Substituted diaza-spiro-[5.5]-undecane derivatives and their use as neurokinin antagonists | Apr 3, 2005 | Issued |
Array
(
[id] => 7225262
[patent_doc_number] => 20050261332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Sulfonamides and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/098315
[patent_app_country] => US
[patent_app_date] => 2005-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28766
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20050261332.pdf
[firstpage_image] =>[orig_patent_app_number] => 11098315
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/098315 | Sulfonamides and uses thereof | Apr 3, 2005 | Abandoned |
Array
(
[id] => 758538
[patent_doc_number] => 07015327
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-21
[patent_title] => 'Anthrapyridone compounds, water-base magenta ink compositions and method of ink-jet recording'
[patent_app_type] => utility
[patent_app_number] => 11/096507
[patent_app_country] => US
[patent_app_date] => 2005-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9576
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/015/07015327.pdf
[firstpage_image] =>[orig_patent_app_number] => 11096507
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/096507 | Anthrapyridone compounds, water-base magenta ink compositions and method of ink-jet recording | Mar 31, 2005 | Issued |
Array
(
[id] => 8270533
[patent_doc_number] => 08212037
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-03
[patent_title] => 'Process for production of optically active quinuclidinols'
[patent_app_type] => utility
[patent_app_number] => 11/887340
[patent_app_country] => US
[patent_app_date] => 2005-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17892
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11887340
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/887340 | Process for production of optically active quinuclidinols | Mar 29, 2005 | Issued |
Array
(
[id] => 5754849
[patent_doc_number] => 20060223998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Synthetic LSD metabolite for preparing haptens used in an LSD metabolite immunoassay'
[patent_app_type] => utility
[patent_app_number] => 11/093676
[patent_app_country] => US
[patent_app_date] => 2005-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 2144
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20060223998.pdf
[firstpage_image] =>[orig_patent_app_number] => 11093676
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/093676 | Synthetic LSD metabolite for preparing haptens used in an LSD metabolite immunoassay | Mar 29, 2005 | Abandoned |
Array
(
[id] => 7020169
[patent_doc_number] => 20050222188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Process for preparing oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone'
[patent_app_type] => utility
[patent_app_number] => 11/093626
[patent_app_country] => US
[patent_app_date] => 2005-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17662
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222188.pdf
[firstpage_image] =>[orig_patent_app_number] => 11093626
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/093626 | Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone | Mar 29, 2005 | Issued |
Array
(
[id] => 4978141
[patent_doc_number] => 20070219375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Novel Compound and Organic Electronic Device Using the Same'
[patent_app_type] => utility
[patent_app_number] => 10/594156
[patent_app_country] => US
[patent_app_date] => 2005-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 24698
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20070219375.pdf
[firstpage_image] =>[orig_patent_app_number] => 10594156
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/594156 | Compound and organic electronic device using the same | Mar 28, 2005 | Issued |
Array
(
[id] => 415302
[patent_doc_number] => 07279486
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-09
[patent_title] => 'Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as ORL1-receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/092503
[patent_app_country] => US
[patent_app_date] => 2005-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44400
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/279/07279486.pdf
[firstpage_image] =>[orig_patent_app_number] => 11092503
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/092503 | Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as ORL1-receptor antagonists | Mar 28, 2005 | Issued |
Array
(
[id] => 7201183
[patent_doc_number] => 20050165092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Crystalline base of citalopram'
[patent_app_type] => utility
[patent_app_number] => 11/090336
[patent_app_country] => US
[patent_app_date] => 2005-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4757
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20050165092.pdf
[firstpage_image] =>[orig_patent_app_number] => 11090336
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/090336 | Crystalline base of citalopram | Mar 23, 2005 | Abandoned |
Array
(
[id] => 7202038
[patent_doc_number] => 20050165244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Crystalline base of citalopram'
[patent_app_type] => utility
[patent_app_number] => 11/090337
[patent_app_country] => US
[patent_app_date] => 2005-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4756
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20050165244.pdf
[firstpage_image] =>[orig_patent_app_number] => 11090337
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/090337 | Crystalline base of citalopram | Mar 23, 2005 | Abandoned |
Array
(
[id] => 6960091
[patent_doc_number] => 20050215792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Transition metal complexes'
[patent_app_type] => utility
[patent_app_number] => 11/088023
[patent_app_country] => US
[patent_app_date] => 2005-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23757
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20050215792.pdf
[firstpage_image] =>[orig_patent_app_number] => 11088023
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/088023 | Transition metal complexes | Mar 22, 2005 | Issued |
Array
(
[id] => 584415
[patent_doc_number] => 07449578
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-11-11
[patent_title] => 'Two-photon absorbing materials with quenched emission'
[patent_app_type] => utility
[patent_app_number] => 11/087236
[patent_app_country] => US
[patent_app_date] => 2005-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 6035
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/449/07449578.pdf
[firstpage_image] =>[orig_patent_app_number] => 11087236
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/087236 | Two-photon absorbing materials with quenched emission | Mar 22, 2005 | Issued |
Array
(
[id] => 7005823
[patent_doc_number] => 20050171136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Modulators of the glucocorticoid receptor and method'
[patent_app_type] => utility
[patent_app_number] => 11/085347
[patent_app_country] => US
[patent_app_date] => 2005-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26972
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20050171136.pdf
[firstpage_image] =>[orig_patent_app_number] => 11085347
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/085347 | Modulators of the glucocorticoid receptor and method | Mar 20, 2005 | Abandoned |
Array
(
[id] => 6959621
[patent_doc_number] => 20050215590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Formamide derivatives for the treatment of diseases'
[patent_app_type] => utility
[patent_app_number] => 11/086035
[patent_app_country] => US
[patent_app_date] => 2005-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36056
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20050215590.pdf
[firstpage_image] =>[orig_patent_app_number] => 11086035
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/086035 | Formamide derivatives for the treatment of diseases | Mar 20, 2005 | Issued |
Array
(
[id] => 5131778
[patent_doc_number] => 20070208175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'PROCESS FOR PREPARING CYCLOHEXANEDIACETIC ACID MONOAMIDE'
[patent_app_type] => utility
[patent_app_number] => 10/599009
[patent_app_country] => US
[patent_app_date] => 2005-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2238
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20070208175.pdf
[firstpage_image] =>[orig_patent_app_number] => 10599009
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/599009 | Process for preparing cyclohexanediacetic acid monoamide | Mar 16, 2005 | Issued |
Array
(
[id] => 5113584
[patent_doc_number] => 20070197500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/599473
[patent_app_country] => US
[patent_app_date] => 2005-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92413
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20070197500.pdf
[firstpage_image] =>[orig_patent_app_number] => 10599473
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/599473 | Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as ORL1-receptor antagonists | Mar 15, 2005 | Issued |
Array
(
[id] => 42880
[patent_doc_number] => 07781445
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-24
[patent_title] => 'Synthesis of indenoisoquinoliniums and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/592849
[patent_app_country] => US
[patent_app_date] => 2005-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13330
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/781/07781445.pdf
[firstpage_image] =>[orig_patent_app_number] => 10592849
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/592849 | Synthesis of indenoisoquinoliniums and methods of use | Mar 14, 2005 | Issued |